Lecture C4 - Anti-fungal Drugs Flashcards

1
Q

How many classes of licensed antifungals are there to treat systemic infections?

A

3 because of selectivity. Fungal cells can be similar to human cells and a lot of processes are the same so if you target fungal processes you may also target human host cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where do antifungals mainly target?

A

Fungal cell membrane or cell wall.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name some antifungals and what they target.

A

Azoles - target sterols, the biosynthesis in the ER.
Echinocandins - target polysaccharide cell wall.
Polyenes - binds to steroid molecules associated with the plasma membrane of fungal cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe polyenes and give an example.

A

Example = Amphotericin B.
Binds to ergosterol in fungal membrane ‘sterol sponge’ and perturbs membrane function.
Specificity related to structural differences in fungal and human sterols and fungal cells having a higher sterol content in their membranes.
Kills the fungal cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the pros and cons of polyenes?

A

Pro - broad spectrum
Con - selectivity is low and can cause toxicity. Only administered systemically.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the effective oral routes for administering amphotericin B?

A

Liposome - drug combined with lipids.
Cochleate - phospholipid, cation containing crystallised structure that the drug can intercalate into the spiral lipid bilayer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does AM-2-19 do?

A

Kills fungi but spares kidney cells.
Structural derivative of AmB that does not bind cholesterol so prevents renal toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe triazoles and give an example.

A

Largest class of antifungals in use.
Example = Fluconazole.
Inhibits steroid formation - ergosterol depleted and replaced with unusual sterols which alters the normal permeability/fluidity of the cell membrane.
By adding a methyl group to fluconazole then it can also treat aspergillum fumigatus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the molecular target of triazoles?

A

Erg11/Cyp51 which catalyses the oxidative removal of the 14 methyl group of lanesterol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the mode of action of triazoles?

A

Erg11 contains an iron protoporphyrin moiety - triazoles bind tot he iron via the nitrogen in the triazole ring, blocking the active site of the enzyme and preventing its function.
Typically fungi-static - does not kill the fungus but stops it from working.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the pros and cons of triazoles?

A

Pros - non-toxic, prophylaxis treatment with fluconazole reduces the incidence of system infections in immunocompromised patients, oral triazoles are more accessible, broad acting.
Cons - resistance to azaleas is common, adverse drug-drug interactions due to interference with hepatic and intestinal cytochrome P-450 enzymes, difficult to control plasma levels of the drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe echinocandins and give an example.

A

Example = Caspofungin.
Target beta-1,3 gluten synthase - Fks1, regulates synthesis of cell wall Beta-1,3 gluten polysaccharides.
Blocks Fks1 to block the synthesis of beta-1,3 gluten synthase so the cell wall can’t be built properly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the pros and cons of echinocandins?

A

Pros - low frequency of toxicity - safest class of antifungals, low frequency of fungal resistance.
Cons - no activity against cryptococcus neoformans and emerging pathogens such as fusarium, only fungistatic against aspergillum species, only administered via IV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the 2 forms of resistance?

A

Primary resistance - intrinsic, occurs in organisms never exposed in that host to the drug of interest.
Secondary - acquired, arises after exposure to the drug, more common.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe resistance to azoles.

A

Because azoles do not kill the fungal cells.
Most C auris isolates are azole reistant, C krusei and C glabrata are intrinsically resistant and increasingly being isolated from patients undergoing immunosuppressant therapies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the mechanisms of resistance from fungal cells?

A

Alteration of drug efflux
Alteration of drug influx
Alteration of target enzymes

17
Q

Describe alteration of drug efflux.

A

CDR transporter proteins are overexpressed in resistant forms of Candida.
Mutations in txn factors that regulate their expression allows for them to be over expressed.
Drug can’t sit in the Fingal cell long enough to have the desired effect.

18
Q

Describe alteration of drug influx.

A

Altered composition of plasma membrane.
Fluconazole resistant isolates of C albicans have decreased amounts of ergosterol and altered phospholipid compositions.
Tac1 regulates the expression of PDR16.
Over expression of PDR16 confers azole resistance by modulating the composition of the plasma membrane and affecting drug uptake or optimal functioning of Cdr1 efflux pump.

19
Q

Describe alteration of target enzymes in resistance to triazoles.

A

Overexpression of Erg11/Cyp51
Point mutations in these reduce affinity for fluconazole.
Enzymes have a haem co-factor in the active site - mutations in this site reduces the affinity of the enzyme for triazoles.

20
Q

What is a dual use antifungal causing?

A

Dual use antifungal used to spray crops and can be used to treat patients.
But a lot of azoles being sprayed onto crop fields, driving resistance in environmental fungi species and therefore driving resistance in A fumigatus to azole.
Resistance seen in patients undergoing therapy but also azole naive patients.

21
Q

Describe resistance to Echinocandins.

A

Not as common to resistance to azoles.
Mutations in Fks1 clustered in 2 hot spots. This significantly decreases the drug sensitivity of gluten synthase.

22
Q

Describe resistance to polyenes.

A

Reports of resistance are limited as these drugs kill the fungal cells.
Reduction in ergosterol content and alterations in sterol content so reduced affinity for AmB.

23
Q

What are some characteristics of the ideal antifungal agent?

A

Broad activity
Low frequency of resistance
Available in oral and IV preparations
Low frequency of adverse events
Minimal drug interactions
Reasonable cost